Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Analytic Treatment Interruption
OTHER
3 trials
Sponsors
Mayo Clinic
, Steven Deeks
, National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HIV
HIV Infections
Phase 1
CAR-T Cells for HIV Infection
Recruiting
NCT04648046
Steven Deeks
HIV Infections
Start: 2021-03-01
End: 2029-12-31
Target: 18
Updated: 2025-07-04
The Tatelo Plus Study
Recruiting
NCT06508749
National Institute of Allergy and Infectious Diseases (NIAID)
HIV, HIV Infections
Start: 2024-11-11
End: 2028-04-21
Target: 41
Updated: 2025-06-10
Unknown Phase
Analytic Treatment Interruption (ATI) to Assess HIV Cure
Enrolling by invitation
NCT02437526
Mayo Clinic
HIV
Start: 2015-05-31
End: 2035-05-31
Target: 10
Updated: 2025-06-05
Related Papers
Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
Frontiers in Medicine
2022-11-14
7 citations
In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells
JCI Insight
2022-11-07
42 citations